Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages.
about
Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.P-glycoprotein-dependent trafficking of nanoparticle-drug conjugatesInvolvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transportImpact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis.In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipineQuantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophagesActive efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter.Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity.Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycinCellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidificationIntracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.P-glycoprotein Inhibition for Optimal Drug Delivery.Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole.Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils.Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coliAutophagic flux inhibition and lysosomogenesis ensuing cellular capture and retention of the cationic drug quinacrine in murine models.Intracellular pharmacokinetics of telithromycin, a ketolide antibiotic, in alveolar macrophages.Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.A human xenobiotic nuclear receptor contributes to nonresponsiveness of Mycobacterium tuberculosis to the antituberculosis drug rifampicin.Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
P2860
Q33836590-530540BB-A46F-41B7-9E9F-4A3E9D365E5CQ34062299-A985C25F-8345-43AF-8BC0-6140453FDFEEQ34301527-EB85BE5B-F03D-4628-91A9-179A4B46FBB4Q34932613-1A9D2D02-6170-437A-956F-F041EF966735Q35065754-97E987D0-D38A-424E-8D61-FB40F5EB2735Q35102754-6AB415B2-8ACC-4B10-BEC5-0097902DEC5EQ35125010-1C94B830-FA77-4A09-BCD9-A9F7DE3B8D49Q35212135-B8116415-2A89-4CB3-A899-7CF29EEAB960Q35912731-579D9FFB-FD5F-466D-AC24-22B3FCE33835Q36490749-079913F2-FC56-4B3E-8EC6-5DB6D50A7DB3Q36670964-3319804A-350E-4CAF-AD49-478801C9E47EQ36960882-21BD29C0-DD14-45DE-8206-791472C81F0FQ37190843-B7F2801C-89DC-4058-80E6-43055E3B7CE9Q38136183-52C46F32-F3EB-4F1F-B69D-5716810C5B8AQ38151858-11B1DFDA-F84B-4915-A1F7-7CA72473E174Q38736649-8ACD5F74-2D35-4954-918B-AB3BD2AF5C21Q39354491-31981984-7E32-4A90-98CC-0A5E3FDB4641Q39715575-C306D01F-A294-421B-98C6-338E9BCA5412Q39831380-9B7F88E1-76CC-4F24-B748-A3E7356E5FBDQ39955443-6F1CA756-5482-482B-8A9C-24979984C507Q42056284-80D766EE-7FB4-407D-8290-500CEDFCD360Q42932532-E765E03B-22BA-401D-B1DC-F7F20DAE8F91Q43048902-3BFE8162-8355-4F6A-B9A1-7BEB7490C64FQ49874435-F08170E5-D793-422B-9A4E-FCFD179C3ACFQ52952104-A555ABB8-750A-4E7E-91D1-E55796F48BB6
P2860
Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@ast
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@en
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@nl
type
label
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@ast
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@en
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@nl
prefLabel
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@ast
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@en
Influence of P-glycoprotein in ...... es in J774 murine macrophages.
@nl
P2093
P2860
P1476
Influence of P-glycoprotein in ...... des in J774 murine macrophages
@en
P2093
Cristina Seral
Hugues Chanteux
Jean-Michel Michot
Marie-Paule Mingeot-Leclercq
P2860
P304
P356
10.1128/AAC.47.3.1047-1051.2003
P407
P577
2003-03-01T00:00:00Z